Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 8.90% | $89.53M | £220.41B | 29.45% | 80 Outperform | |
| HSBC Holdings | 8.60% | $86.51M | £205.11B | 49.44% | 80 Outperform | |
| Shell (UK) | 6.21% | $62.44M | £150.06B | 0.57% | 73 Outperform | |
| Rolls-Royce Holdings | 4.52% | $45.48M | £108.65B | 142.15% | 71 Outperform | |
| Unilever | 4.19% | $42.17M | £103.45B | -6.99% | 72 Outperform | |
| British American Tobacco | 3.57% | $35.93M | £88.17B | 36.88% | 71 Outperform | |
| GlaxoSmithKline | 3.17% | $31.85M | £76.08B | 39.76% | 77 Outperform | |
| Barclays | 2.83% | $28.42M | £67.09B | 87.91% | 78 Outperform | |
| BP p.l.c. | 2.73% | $27.47M | £65.04B | 0.12% | 71 Outperform | |
| Rio Tinto | 2.68% | $26.96M | £101.74B | 24.66% | 82 Outperform |